KODIFORM THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

4 employees website.com
Research and experimental development on biotechnology
K

KODIFORM THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 5 Jan 2024 Active London, England 4 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 9 Jul 2025 Next due 31 Oct 2026 6 months remaining
Confirmation Submitted 13 Jan 2026 Next due 18 Jan 2027 9 months remaining
Net assets £4M
Total assets £4M
Total Liabilities £88K
Charges None No charges registered

Contact & Details

Contact

Registered Address

Scale Space Building C Scale Space Building C 58 Wood Lane London W12 7RZ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for KODIFORM THERAPEUTICS LIMITED (15390647), an active company based in London, England. Incorporated 5 Jan 2024. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£3.96M

Net Assets

£4.18M

Total Liabilities

£88.42k

Turnover

N/A

Employees

4

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 5,500,000 Shares £5.00m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Mar 2024500,000£5£0
28 Mar 20245,000,000£5.00m£1

Officers

Officers

3 active
Status
Angela Jane RobertsDirectorBritishUnited Kingdom485 Jan 2024Active
Benedict StephensSecretaryUnknownUnknown19 Mar 2024Active
Sally Marianne DewhurstDirectorBritishUnited Kingdom363 Apr 2024Active

Shareholders

Shareholders (6)

Oxford Science Enterprises Plc
66.7%
5,000,000
Terence Rabbitts
20.0%
1,500,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active
Active
Notified 3 Apr 2024
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Terence Rabbitts

British

Active
Notified 5 Jan 2024
Residence United Kingdom
DOB June 1946
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

KODIFORM THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Mar 2026OfficersAppointment of Dr Thorsten Nowak as director on 2026-02-11
13 Jan 2026Confirmation StatementConfirmation statement made on 2026-01-04 with no updates
9 Jul 2025AccountsAnnual accounts made up to 2025-01-31
9 Jan 2025Confirmation StatementConfirmation statement made on 2025-01-04 with updates
10 Dec 2024AddressChange Registered Office Address Company With Date Old Address New Address
17 Mar 2026 Officers

Appointment of Dr Thorsten Nowak as director on 2026-02-11

13 Jan 2026 Confirmation Statement

Confirmation statement made on 2026-01-04 with no updates

9 Jul 2025 Accounts

Annual accounts made up to 2025-01-31

9 Jan 2025 Confirmation Statement

Confirmation statement made on 2025-01-04 with updates

10 Dec 2024 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Appointment of Dr Thorsten Nowak as director on 2026-02-11

1 months ago on 17 Mar 2026

Confirmation statement made on 2026-01-04 with no updates

3 months ago on 13 Jan 2026

Annual accounts made up to 2025-01-31

9 months ago on 9 Jul 2025

Confirmation statement made on 2025-01-04 with updates

1 years ago on 9 Jan 2025

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 10 Dec 2024